文献速递帕金森病与运动障碍

丘脑底核深部脑刺激在A53T α-突触核蛋白帕金森病大鼠模型中具有神经保护作用

Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α-synuclein Parkinson's disease rat model.
PubMed 文献 · Ann Neurol · 2017-06-09

该研究在AAV1/2介导的人突变A53T α-突触核蛋白过表达帕金森病大鼠模型中,于行为和多巴胺能缺陷出现后给予丘脑底核深部脑刺激(STN-DBS)3周。结果显示刺激组运动功能显著改善,且黑质酪氨酸羟化酶阳性神经元数量增加,提示STN-DBS可能具有神经保护和疾病修饰作用。

要点

  • 在A53T α-突触核蛋白过表达PD大鼠模型中,STN-DBS可逆转运动缺陷。
  • STN-DBS组黑质酪氨酸羟化酶阳性神经元数量较刺激关闭组增加约29%。
  • 运动改善在刺激关闭后仍维持,提示潜在疾病修饰效应。

核心结论

  • STN-DBS在机制相关的帕金森病大鼠模型中表现出假定的神经保护和疾病修饰作用。

研究设计与样本

  • 研究采用AAV1/2驱动的人突变A53T α-突触核蛋白过表达PD大鼠模型,单侧黑质注射载体或对照载体。
  • 注射3周后,在行为和多巴胺能缺陷出现后,于载体注射侧黑质同侧植入STN-DBS电极,刺激3周,对照组分刺激关闭,动物于6周时处死。

主要发现

  • AAV1/2-A53T-aSyn注射后6周,刺激关闭组在单颗粒取食任务中运动表现较术前下降82%(p < 0.01)。
  • 经过3周主动刺激,刺激开启组较刺激关闭组运动表现改善约400%(p < 0.05)。
  • 刺激关闭后运动改善仍维持,且刺激开启组黑质酪氨酸羟化酶阳性神经元数量较刺激关闭组增加约29%(p < 0.05)。

临床怎么用

  • 该动物模型结果支持在帕金森病患者中进一步评估STN-DBS的疾病修饰潜力,但尚未转化为临床推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a highly effective symptomatic therapy for motor deficits in Parkinson's disease (PD). An additional, disease-modifying effect has been suspected from studies in toxin-based PD animal models, but these models do not reflect the molecular pathology and progressive nature of PD that would be required to evaluate a disease-modifying action. Defining a disease-modifying effect could radically change the way in which DBS is used in PD. METHODS: We applied STN-DBS in an adeno-associated virus (AAV) 1/2-driven human mutated A53T α-synuclein (aSyn)-overexpressing PD rat model (AAV1/2-A53T-aSyn). Rats were injected unilaterally, in the substantia nigra (SN), with AAV1/2-A53T-aSyn or control vector. Three weeks later, after behavioral and nigrostriatal dopaminergic deficits had developed, rats underwent STN-DBS electrode implantation ipsilateral to the vector-injected SN. Stimulation lasted for 3 weeks. Control groups remained OFF stimulation. Animals were sacrificed at 6 weeks. RESULTS: Motor performance in the single pellet reaching task was impaired in the AAV1/2-A53T-aSyn-injected stim-OFF group, 6 weeks after AAV1/2-A53T-aSyn injection, compared to preoperative levels (-82%; p < 0.01). Deficits were reversed in AAV1/2-A53T-aSyn, stim-ON rats after 3 weeks of active stimulation, compared to the AAV1/2-A53T-aSyn stim-OFF rats (an increase of ∼400%; p < 0.05), demonstrating a beneficial effect of DBS. This motor improvement was maintained when the stimulation was turned off and was accompanied by a higher number of tyrosine hydroxylase+ SN neurons (increase of ∼29%), compared to AAV1/2-A53T-aSyn stim-OFF rats (p < 0.05). INTERPRETATION: Our data support the putative neuroprotective and disease-modifying effect of STN-DBS in a mechanistically relevant model of PD. Ann Neurol 2017;81:825-836.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Musacchio T, Rebenstorff M, Fluri F, et al. Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α-synuclein Parkinson's disease rat model. Ann Neurol. 2017. PMID: 28470693. doi:10.1002/ana.24947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。